Nuclein, LLC was founded in 2017 by long-time Austin biotechnology entrepreneurs Alan Blake and Dr. Richard Crockett. The company's vision is to enable simple, affordable, rapid, and accurate disease testing for everyone.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 03/26/21 | $14,000,000 | Series B |
Trinity Private Equity Group | undisclosed |
